Definitive Healthcare shares are trading lower after JP Morgan downgraded the stock from Neutral to Underweight and lowered its price target from $7 to $5. Also, Baird maintained a Neutral rating on the stock but lowered its price target from $8 to $6.
Portfolio Pulse from Benzinga Newsdesk
Definitive Healthcare shares are trading lower following a downgrade by JP Morgan from Neutral to Underweight, with a price target reduction from $7 to $5. Baird also maintained a Neutral rating but lowered its price target from $8 to $6.
July 31, 2024 | 12:55 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Definitive Healthcare shares are trading lower after JP Morgan downgraded the stock from Neutral to Underweight and lowered its price target from $7 to $5. Baird also maintained a Neutral rating but lowered its price target from $8 to $6.
The downgrade by JP Morgan from Neutral to Underweight and the significant reduction in price targets by both JP Morgan and Baird are likely to negatively impact investor sentiment and put downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100